4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Seizures in 1 studies
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We determined tonic-clonic seizure duration in rats given ECS with caffeine (0-175 mg/kg, IP) after a course of one or six daily ECS." | 5.29 | Reduced proconvulsant activity of caffeine in rats after a series of electroconvulsive seizures. ( Fochtmann, L; Francis, A, 1995) |
| "We determined tonic-clonic seizure duration in rats given ECS with caffeine (0-175 mg/kg, IP) after a course of one or six daily ECS." | 1.29 | Reduced proconvulsant activity of caffeine in rats after a series of electroconvulsive seizures. ( Fochtmann, L; Francis, A, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, A | 1 |
| Fochtmann, L | 1 |
1 other study available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Seizures
| Article | Year |
|---|---|
Reduced proconvulsant activity of caffeine in rats after a series of electroconvulsive seizures.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Caffeine; Dose-Response Relationship, Drug; | 1995 |